Nuno Sepúlveda and colleagues from a number of institutions (including Charité – Universitätsmedizin Berlin and the London School of Hygiene and Tropical Medicine) have recently published more results from their ME Research UK-funded study looking at whether antibody responses against Epstein-Barr virus can serve as biomarkers for ME/CFS.
You can read a brief summary of their results here, and we will post a more detailed explanation of the research shortly.
